Giersiefen, Helmut (Curacyte 200808 CEO) |
Chief Executive Officer (CEO) |
Curacyte (Group) |
München (Munich) |
Zaby, Andreas (Curacyte 200601) |
n. a. |
Curacyte (Group) |
München (Munich) |
Hohenhester, Michael (Curefab GmbH 2008– CEO + Co-founder) |
Chief Executive Officer (CEO) |
Curefab GmbH |
München (Munich) |
Wittmeier, Sebastian (Curefab GmbH 2008– CTO + Co-founder) |
Chief Technology/Technical Officer (CTO) |
Curefab GmbH |
München (Munich) |
Fakih, Sarah (CureVac 202007– VP Investor Relations before MorphoSys + Qiagen) |
Public Relations Manager / Investor Relations Manager |
CureVac (Group) |
Tübingen |
Neermann, Jörg (Curexsys 202105– CEO before Life Sciences Partners Munich+ DVC + Atlas Venture) |
Chief Executive Officer (CEO) |
Curexsys GmbH |
Göttingen |
Bauer, Reinhard (Daiichi Sankyo Europe 200803 CEO) |
Chief Executive Officer (CEO) |
Daiichi Sankyo (Group) |
München (Munich) |
Hirashima, Shoji (Daiichi Sankyo 201302 Managing Director of U3 Pharma GmbH) |
Managing Director |
Daiichi Sankyo (Group) |
Martinsried |
Hansen, Dirk (Phenomenex 201003 Marketing Manager Europe) |
Sales Manager / Marketing Manager |
Danaher (Group) |
Aschaffenburg |
Heinrich, Günther (Epidauros Founder) |
Company Founder |
Danaher (Group) |
Bernried |
Kaspar, Dagmar (Epidauros 200707– VP BusDev + Marketing before Nordic Bioscience) |
Business Development Manager / Strategy Manager |
Danaher (Group) |
Bernried |
Neuhaus, Eckhart (Advalytix co-founder) |
n. a. |
Danaher (Group) |
München (Munich) |
Reschauer, Stephan (Epidauros 200603 Patents + Licensing) |
n. a. |
Danaher (Group) |
Bernried |
Roschmann, Elke (Epidauros 200707– promoted to Head Strategic Development + Licensing) |
n. a. |
Danaher (Group) |
Bernried |
Scriba, Jürgen (Advalytix co-founder) |
n. a. |
Danaher (Group) |
München (Munich) |
Wixforth, Achim (Advalytix co-founder) |
n. a. |
Danaher (Group) |
München (Munich) |
Schmuhl, Heike (Dechert LLP 200809 Munich) |
n. a. |
Dechert (Group) |
München (Munich) |
Moosbauer, Julia (Deepc 202303 COO + Co-Founder) |
Chief Operating Officer (COO) |
Deepc GmbH |
München (Munich) |
Pfister, Franz (Deepc 202303 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Deepc GmbH |
München (Munich) |
Gleba, Yurijus (Yuri) (Icon Genetics 200501 CEO) |
Chief Executive Officer (CEO) |
Denka (Group) |
Freising |
Homberg, Peter (Dentons/Salans 201211 Partner Ffm before Raupach & Wollter-Elmendorff + Jones Day + Roche) |
Attorney / Lawyer |
Dentons (Group) |
Frankfurt am Main |
Oldekor, Herr |
n. a. |
Deutsche Bank (Group) |
München (Munich) |
Haugg, Norbert |
n. a. |
Deutsches Patent- und Markenamt |
München (Munich) |
Prehn, Guido (DPE Deusche Private Equity 201706 Partner) |
Partner (venture partner) |
DPE Deutsche Private Equity GmbH |
München (Munich) |
Rant, Ulrich (Dynamic Biosensors GmbH 201301 Managing Director (CEO) + Co-Founder) |
Chief Executive Officer (CEO) |
Dynamic Biosensors (Group) |
Martinsried |
Scholl, Dirk Oliver (Dynamic Biosensors GmbH 201301 Managing Director (CFO)) |
Managing Director |
Dynamic Biosensors (Group) |
Martinsried |
Strasser, Ralf (Dynamic Biosensors 202209 COO + Co-Founder) |
Chief Operating Officer (COO) |
Dynamic Biosensors (Group) |
Martinsried |
Teetz, Wolfram (eADMET GmbH 201109 Managing Director) |
Managing Director |
eADMET GmbH |
Neuherberg |
Tetko, Igor (eADMET GmbH 201109 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
eADMET GmbH |
Neuherberg |
Brandis, Hendrik (Earlybird 201807 Managing Director) |
Managing Director |
Earlybird (Group) |
München (Munich) |
Nagel, Christian (Earlybird 201807 Managing Director) |
Managing Director |
Earlybird (Group) |
München (Munich) |
Rasche, Thom (Earlybird 200809 Partner) |
Partner (venture partner) |
Earlybird (Group) |
München (Munich) |
Müller, Kei Wieland (Ebenbuild 202008) |
Chief Executive Officer (CEO) |
Ebenbuild GmbH |
München (Munich) |
Hein, Mich (Electrochaea 202201 CEO) |
Chief Executive Officer (CEO) |
Electrochaea GmbH |
Martinsried |
Gauer, Christoph (EliTech Group 202312 CEO before Siemens + Olympus + Advalytix) |
Chief Executive Officer (CEO) |
Elitech (Group) |
Puteaux |
Fagerberg, Jan (Enterome 202103 CMO formerly Micromet 200911 SVP + CMO) |
Chief Medical Officer (CMO) |
Enterome S.A. |
Paris |
Keppler, Adrian (EOS Group 201910 Managing Director of EOS GmbH) |
Managing Director |
EOS Group (Electro Optical Systems) (Group) |
Krailling |
Langer, Hans J. (EOS Group 1989–201910 CEO + Founder) |
Chief Executive Officer (CEO) |
EOS Group (Electro Optical Systems) (Group) |
Krailling |
Langer, Marie (EOS Group 201910– CEO of EOS GmbH) |
Chief Executive Officer (CEO) |
EOS Group (Electro Optical Systems) (Group) |
Krailling |
Paffrath, Eric (EOS Group 201910 Managing Director of EOS GmbH) |
Managing Director |
EOS Group (Electro Optical Systems) (Group) |
Krailling |
Lensky, Stephan (EpimAb Biotherapeutics 201610 COO/CBO) |
Chief Operating Officer (COO) |
EpimAb Biotherapeutics (Group) |
Shanghai |
Solis, Victor (EpiQMAx GmbH 201903 Managing Director + Co-Founder) |
Managing Director |
EpiQMAx GmbH |
Martinsried |
Völker-Albert, Moritz (EpiQMAx GmbH 201903 Managing Director + Co-Founder) |
Managing Director |
EpiQMAx GmbH |
Martinsried |
Rothe, Joachim G. (Life Sciences Partners München 201511 Partner) |
Partner (venture partner) |
EQT (Wallenberg family) (Group) |
München (Munich) |
Paschlau, Joachim (ERC GmbH 201105 Managing Director) |
Managing Director |
ERC Gesellschaft für den Vertrieb wissenschaftlicher Geräte mbH (ERC GmbH) |
Riemerling |
von Velasco, Sabine (ERC GmbH 201106 Marketing) |
Sales Manager / Marketing Manager |
ERC Gesellschaft für den Vertrieb wissenschaftlicher Geräte mbH (ERC GmbH) |
Riemerling |
Platte, Ulrich (eTheRNA Immunotherapies 202110 CFO formerly sinYmed UG 201510– Managing Director) |
Chief Financial Officer (CFO) |
eTheRNA (Group) |
Belgium_oo |
Dittmar, Gita (Ethris 201708 Head Corp Development before Biogen Idex + Dance Biopharma) |
Business Development Manager / Strategy Manager |
Ethris GmbH |
Martinsried |
Planck, Christian (Ethris 201301 Managing Director + Co-founder) |
Managing Director |
Ethris GmbH |
Martinsried |
Rudolph, Carsten (Ethris 201301 Managing Director + Co-Founder) |
Managing Director |
Ethris GmbH |
Martinsried |
Wawrzinek, Christian (Ethris 202201– Managing Director + Chief Corp Strategy Officer + Co-Founder of Laureus Capital) |
Managing Director |
Ethris GmbH |
Martinsried |
Beck, Jan-Philipp (EU (govt) 202111 CEO of EIT Health) |
Chief Executive Officer (CEO) |
EU (govt) |
München (Munich) |
Neubeck, Peter (Kurma Partners 201901 Partner + Head of Munich Office before TVM Capital + Novartis + McKinsey) |
Partner (venture partner) |
Eurazeo (Group) |
München (Munich) |
Becker, Thomas |
n. a. |
Eurofins (Group) |
Ebersberg |
Deininger, Werner (Entelechon GmbH 200709 Managing Director) |
Managing Director |
Eurofins (Group) |
Bad Abbach |
Grimminger, Carola (Eurofins 201410 Marketing Manager at Eurofins Genomics GmbH) |
Sales Manager / Marketing Manager |
Eurofins (Group) |
Ebersberg |
Huber, Jutta (Eurofins 201405 Managing Director Eurofins Genomics GmbH before MWG Biotech) |
Managing Director |
Eurofins (Group) |
Ebersberg |
Koehler, Uwe (Eurofins 201603 Head Gene Synthesis + Molecular Biology at Eurofins Genomics) |
President/Director/Head Business Group/Unit/Division |
Eurofins (Group) |
Ebersberg |
Persigehl, Peter (Eurofins 201405 Managing Director at Eurofins Genomics GmbH) |
Managing Director |
Eurofins (Group) |
Ebersberg |
Poddevin, Bruno (Eurofins 201007 SVP Genomic Services) |
President/Director/Head Business Group/Unit/Division |
Eurofins (Group) |
Ebersberg |
Precht, Engelbert (Medigenomix 200809 and BIO Deutschland) |
Managing Director |
Eurofins (Group) |
München (Munich) |
Schlossmacher, Julian (Eurofins 202004 Head of Marketing + Communications Europe at Eurofins Genomics) |
Sales Manager / Marketing Manager |
Eurofins (Group) |
Ebersberg |
Weichselgartner, Michael |
n. a. |
Eurofins (Group) |
Ebersberg |
Wiedemann, Sonja (Eurofins 201801 Managing Director at Eurofins Genomics GmbH) |
Managing Director |
Eurofins (Group) |
Ebersberg |
Giroud, Gérard (European Patent Office 200503) |
n. a. |
European Patent Organisation (EPO) |
München (Munich) |
Rolka, Felix Shimon (Evanium Healthcare 201905 Managing Director) |
Managing Director |
Evanium Healthcare GmbH |
Regensburg |
Godl, Klaus (Kinaxo 200910 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Evotec (Group) |
Martinsried |
Tebbe, Andreas (Kinaxo 200708– Head Mass Spectrometry before post doc scientist at Roche Research Centre) |
Head Mass Spectrometry / NMR Laboratory (industry) |
Evotec (Group) |
Martinsried |
Ullmann, Dirk (Evotec 202209 Global Head Drug Discovery Services before Proteros Biostructures + Evotec) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Evotec (Group) |
Hamburg |
Mummenbrauer, Torsten (ExeVir Bio 202006– CEO before Velvio Gmbh + Hookipa + MorphoSys + GSK Vaccines) |
Business Development Manager / Strategy Manager |
ExeVir Bio B.V. |
Zwijnaarde |
Gärtner, Kathrin (Eximmium) |
n. a. |
Eximmium Biotechnologies (DE) |
München (Munich) |
Müller, Achim (EyeSense 201101 Managing Director) |
Managing Director |
EyeSense GmbH |
Großostheim |
Heiberger, Kurt (Eyesight & Vision 201006– Managing Director + Co-founder) |
Managing Director |
Eyesight & Vision GmbH |
Nürnberg (Nuremberg) |
Perl, Thomas (Eyesight & Vision 201110 Managing Director Sales + Marketing) |
Managing Director |
Eyesight & Vision GmbH |
Nürnberg (Nuremberg) |
Kühn, Thomas (FarmInsect 202006 Managing Director) |
Managing Director |
FarmInsect GmbH |
München (Munich) |
Fuchs, Arno (FCF Fox Corporate Finance 202306 Managing Director) |
Managing Director |
FCF Fox Corporate Finance GmbH |
München (Munich) |
Klozenbücher, Mathias (FCF Fox Corporate Finance 202306– Managing Director Life Sciences before Siemens Healthineers) |
Managing Director |
FCF Fox Corporate Finance GmbH |
München (Munich) |
Lindner, Kerstin (FCF Fox Corporate Finance 202306 Head of Communication) |
Public Relations Manager / Investor Relations Manager |
FCF Fox Corporate Finance GmbH |
München (Munich) |
Schott, Mathias (FCF Fox Corporate Finance –202305 Managing Director Life Sciences LEFT 6/23) |
Managing Director |
FCF Fox Corporate Finance GmbH |
München (Munich) |
Fenzl, Edgar J. (FGK Clinical Research 201411 Managing Director + Co-founder) |
Managing Director |
FGK Clinical Research GmbH |
München (Munich) |
Krauss, Martin (FGK Clinical Research 201411 Managing Director + Co-founder) |
Managing Director |
FGK Clinical Research GmbH |
München (Munich) |
Winzer, Ludwig (Ocimum Germany GmbH 200606– Managing Director) |
Managing Director |
Ficus Enterprises (Group) |
Ebersberg |
Ragotzky, Klaus (Fidura 202011 Managing Director + Chairman of Advisory Board) |
Managing Director |
Fidura Private Equity Fonds (Group) |
München (Munich) |
Weil, Ingrid (Fidura Private Equity Fonds 201311 Managing Director of IWF Fondsconsult GmbH) |
Managing Director |
Fidura Private Equity Fonds (Group) |
Grünwald |
Pöpping, Bert (FOCOS GbR 201703– Co-Owner before Mérieux NutriSciences + GROFOR + Eurofins) |
Research & Development Manager |
FOCOS GbR (FOCOS Food Consulting) – Dr. Bert Pöpping + Dr. Carmen Diaz-Amigo |
Alzenau |
Falcenberg, Matthias (Forbion 201604– Analyst at Munich Office before at MPI of Biochemistry) |
Analyst (Financial / Industry) |
Forbion (Group) |
München (Munich) |
Lohoff, Tim (Forbion 202210 Analyst) |
Analyst (Financial / Industry) |
Forbion (Group) |
München (Munich) |
Reithinger, Holger (Forbion 201004– Managing Director Forbion Capital Partners Munich before GLSV Munich + 3i Germany) |
Managing Director |
Forbion (Group) |
München (Munich) |
Brockmeyer, Carsten (Formycon 201305 CEO) |
Chief Executive Officer (CEO) |
Formycon (Group) |
Martinsried |
Glombitza, Stefan (Formycon 202207– CEO joined 201610 as COO) |
Chief Executive Officer (CEO) |
Formycon (Group) |
Martinsried |
Hampl, Bernhard (Formycon 201403– Advisory Board Member former CEO of Eon Labs/Sandoz US) |
Advisory Board member |
Formycon (Group) |
Martinsried |
Mikulcik, Nicola (Formycon 202206– CBO before Bioeq GmbH + Hexal + Sandoz International) |
Chief Business Officer (CBO) |
Formycon (Group) |
Martinsried |
Seidl, Andreas (Formycon 202207– CSO beforeLeukocare + Novartis + Sandoz Biopharmaceuticals + Hexal) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Formycon (Group) |
Martinsried |
Spillner, Enno (Formycon 202304– CFO before Evotec + 4SC + BioM Venture Capital GmbH) |
Chief Financial Officer (CFO) |
Formycon (Group) |
Martinsried |
McCamish, Mark A. (Forty Seven 201705– CEO before Novartis/Sandoz + PDL Biopharma + Amgen + Abbott) |
Chief Executive Officer (CEO) |
Forty Seven Inc. |
Menlo Park, CA |
Buller, Ulrich (Fraunhofer 200811 Research Director) |
n. a. |
Fraunhofer (Group) |
München (Munich) |
Fackler, Thomas |
n. a. |
Fraunhofer (Group) |
München (Munich) |
Grättinger, Mira (European ScreeningPort 201011 Vice President before NascaCell Technologies) |
n. a. |
Fraunhofer (Group) |
Hamburg |
Müller, Hubert (Fraunhofer PST 200407) |
n. a. |
Fraunhofer (Group) |
München (Munich) |
Brosnan, Michael (Fresenius Medical Care 201804 CFO + proposed to MorphoSys Supervisory Board) |
Chief Financial Officer (CFO) |
Fresenius (Group) |
Bad Homburg |